Navigation Links
Hospira Announces U.S. Approval of Generic Docetaxel
Date:3/9/2011

out Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.

Private Securities Litigation Reform Act of 1995 --

A Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the growth opportunities for generic specialty injectable products. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, legal, regulatory, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks, uncertainties and factors discussed under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Hospira's latest Annual Report on Form 10-K filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
2. Hospira MedNet™ Portal Safety Software Benchmarking System Debuts at HIMSS
3. Hospira to Present at Upcoming Investor Conferences
4. Hospira Announces FDA Approval of Topotecan Injection
5. Hospira Reports Fourth-Quarter and Full-Year 2010 Results
6. Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 Projections
7. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
8. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
9. Hospira to Host Conference Call for Third-Quarter 2010 Results
10. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
11. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013  MedVantx, Inc., the company that has ... announced today the Company has completed a major expansion ... pharmaceutical products and the upgrade of its systems to ... in its specialty home delivery pharmacy in ... pharmaceutical manufacturers, physicians, health systems and payors novel distribution ...
(Date:5/23/2013)... 2013   BioLife Solutions , Inc. (OTC:BLFS), a ... hypothermic storage and cryopreservation freeze ... media manufacturer , today announced its participation at the ... 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President and ...
(Date:5/23/2013)... TOKIO , 22. Mai 2013 ... Weiteren Ranbaxy), eine Tochtergesellschaft von Daiichi ... Sankyo), gab am 22. Mai die ... letzten Jahren ergriffen hat, um sich ... ( http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html ). ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... 2011 Reportlinker.com announces that ... is available in its catalogue: ... Acid Testing Market--New Product Development ... For Instrument and Reagent Suppliers ...
... NEW YORK, June 20, 2011 Reportlinker.com ... is available in its catalogue: ... 2011 http://www.reportlinker.com/p0558499/Top-Medical-Devices-and-Imaging-Technologies-2011.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices ... medical device and imaging technologies that have ...
Cached Medicine Technology:Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 2Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 3Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 4Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 5Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 6Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 7Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 8Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 9Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 10Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 11Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 12Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 13Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 14Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 15Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers 16Reportlinker Adds Top Medical Devices and Imaging Technologies 2011 2
(Date:5/23/2013)... (PRWEB) May 23, 2013 NDI ... funds and develops innovative neurodevice technologies, has launched ... (DBI). DBI will commercialize its groundbreaking technology ... (DBS) therapy for patients with Parkinson’s disease. ... Parkinson’s disease and generates more than $275 million ...
(Date:5/23/2013)... little was scientifically known about the human potential to ... people who are suffering in a way that motivates ... at the Center for Investigating Healthy Minds at the ... adults can be trained to be more compassionate. The ... Science , is the first to investigate whether training ...
(Date:5/23/2013)... connections in the brains of people affected by ... Peter Williamson, from Western University, to gain a ... important diseases. Dr. Williamson and colleagues have ... are disrupted in different psychiatric diseases. These ... Meeting, the annual meeting of the Canadian Association ...
(Date:5/23/2013)... DRE, Inc. is now offering the DRE ... upgrade older model DRE or BFW halogen headlights to ... , DRE and BFW customers can easily and affordably ... to LED with DRE’s American-made Xavier-C3 LED headlight conversion ... a bright, clean and even field of illumination with ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... to announce the launch of Current Digital, a ... web development and digital marketing needs. Companies now ... a strategic business necessity. This can often leave ... creative strategy on preselected software platforms that they ...
Breaking Medicine News(10 mins):Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3Health News:Study shows people can be trained to be more compassionate 2Health News:Study shows people can be trained to be more compassionate 3Health News:Study shows people can be trained to be more compassionate 4Health News:Researchers identify networks of neurons in the brain that are disrupted in psychiatric disease 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 2Health News:Verndale Launches Current Digital, a Technology Partner for Ad and Creative Agencies 3
... in French . ,OTTAWA (June ... Health, announced today that the Government of Canada is ... principal medical isotope affected by the current shutdown at ... isotopes in combination with imaging technologies to diagnose and ...
... Extending health insurance coverage to all children in the ... benefits that are greater than the costs, according to ... Public Policy. "Providing health insurance to all children ... Ho, chair in health economics at the Baker Institute ...
... Association for Molecular Pathology (AMP) today released the text ... Federal Coordinating Council for Comparative Effectiveness Research (CER) in ... on which to focus CER activities. "CER is ... makers who see it as a method to examine ...
... season will soon arrive in the Asian territories and culicine ... the virus that causes Japanese Encephalitis (JE), which kills 10-15,000 ... the largest provider of travel medical services in the U.S. ... FDA, and is ready for distribution in the United States. ...
... (Nasdaq: BMRN ) announced today that the temporary ... is not expected to have any impact on Aldurazyme supply ... fill at the Allston Landing facility was in September 2008. ... vialed inventory on hand, utilizes a second fill finish supplier ...
... CRYSTAL, Minn., June 16 On June 4, 2009, Herzing University ... to begin a Bachelor of Science in Nursing ... of preparation. , , A new medical lab, extensive ... few of the additions brought to campus to prepare for the ...
Cached Medicine News:Health News:Providing health insurance for US children would be cheaper than expected, study says 2Health News:AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 2Health News:AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 3Health News:Monsoon Season will Bring Japanese Encephalitis 2Health News:Temporary Production Interruption at Allston Landing Manufacturing Facility Has No Impact on Aldurazyme 2Health News:Herzing University, Minneapolis Receives Board of Nursing Approval 2
At 14 cm point, ruler is bent at 90 degrees angle brought to a blunt point at 15 cm....
Colorado Microneedles offer the surgeon precision in cutting and coagulation, without the expense and inconvenience of a laser. The needles may also be used for dissecting large areas such as the sca...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: